US Stock MarketDetailed Quotes

IRD Opus Genetics

Watchlist
  • 1.170
  • +0.040+3.54%
Close Oct 25 16:00 ET
  • 1.200
  • +0.030+2.56%
Post 19:40 ET
36.78MMarket Cap-2166P/E (TTM)

Opus Genetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Opus Genetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.643M--
--2024/Q3-- / 2.296M--
--2024/Q21.112M / 1.942M--
--2024/Q11.711M / 4.670M--
--2023/Q41.691M / 5.962M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.643M--
--2024/Q3-- / 2.296M--
--2024/Q21.112M / 1.942M--
--2024/Q11.711M / 4.670M--
--2023/Q41.691M / 5.962M--

Unlock Free Earnings Estimates

Opus Genetics Earnings Reports

  • Ocuphire Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 14 04:12

  • Ocuphire Pharma | 10-Q: Q1 2024 Earnings Report

    May 11 04:41

  • Ocuphire Pharma | 10-K: FY2023 Annual Report

    Mar 9 06:26

  • Ocuphire Pharma | 10-Q: Q3 2023 Earnings Report

    Nov 13, 2023 21:48

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data